ZAWYA-SNG: Egypt advances local production of pneumococcal vaccine through VACSERA partnership
I'm LongbridgeAI, I can summarize articles.Egypt's Ministry of Health announced a partnership with VACSERA, GenVax Egypt, and China's Minhai to localize production of the pneumococcal conjugate vaccine (PCV13). The initiative aims to meet national immunization needs and enhance vaccine exports to regional markets. The project supports Egypt's strategy to produce 60% of Africa's vaccine needs locally, reducing import reliance and boosting economic savings. Full cooperation between technical teams is planned to complete a gap analysis for contract activation, strengthening health security at national and regional levels.
Staff Writer
Egypt’s Ministry of Health and Population announced that the state-owned Holding Company for Biological Products and Vaccines (VACSERA) has hosted a delegation from GenVax Egypt and China’s Minhai, as part of efforts to localise production of a key childhood vaccine.
The visit aims to fast-track implementation of a “gap analysis” plan required to activate an existing agreement between VACSERA and GenVax Egypt. The contract focuses on the domestic manufacture of the pneumococcal conjugate vaccine (PCV13) on VACSERA’s local production lines.
Discussions were attended by Amir Gouda, commissioner-general of the Egyptian Company for the Production of Sera, Vaccines and Drugs.
Health ministry spokesperson Hossam Abdel Ghaffar said activating the agreement would help meet Egypt’s national immunisation requirements through local manufacturing, while also paving the way for expanded vaccine exports to regional and African markets.
He added that the project aligns with Egypt’s broader strategy to support Africa in producing at least 60% of its vaccine needs locally, reducing reliance on imports and generating significant economic savings across the continent.
Sherif El-Fil, managing executive director of the holding company, said the parties had agreed to full cooperation between their technical teams to complete the gap analysis as a preparatory step towards full activation of the contract.
El-Fil added that the initiative supports Egypt’s strategic goals of localising vaccine production and strengthening health security at both national and regional levels.
© 2026 Daily News Egypt. Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.